RhumbLine Advisers’s Concord Medical Services CCM Stock Holding History

RhumbLine Advisers’s Portfolio CCM Stock Details CCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-258	Closed	-$1.48K	–	4133
2025 Q2	$1.48K	Sell	258 -37	-13%	-$231	﹤0.01%	4014
2025 Q1	$1.18K	Sell	295 -2,165	-88%	-$10.1K	﹤0.01%	4020
2024 Q4	$13.2K	Hold	2,460	–	–	﹤0.01%	3849
2024 Q3	$17.2K	Buy	2,460 +474	+24%	+$3.45K	﹤0.01%	3830
2024 Q2	$18.9K	Buy	1,986 +1,440	+264%	+$9.65K	﹤0.01%	3880
2024 Q1	$3.02K	Hold	546	–	–	﹤0.01%	4045
2023 Q4	$6K	Hold	546	–	–	﹤0.01%	3945
2023 Q3	$6.98K	Hold	546	–	–	﹤0.01%	3928
2023 Q2	$7.53K	Buy	+546	New	+$7.38K	﹤0.01%	4000

Other funds holding CCM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

RhumbLine Advisers's CCM Position: Q3 2025 in Review

RhumbLine Advisers sold out of Concord Medical Services (CCM) in Q3 2025, closing a stake of 258 shares — an estimated $1.48K sold.

RhumbLine Advisers first reported a position in CCM in Q2 2023 and held it in 9 quarters. The position peaked at $18.9K in Q2 2024. 5 funds tracked by Wall St. Rank hold CCM as of Q3 2025.

RhumbLine Advisers reported no remaining Concord Medical Services position as of Q3 2025 after selling out during the quarter.
RhumbLine Advisers sold 258 Concord Medical Services shares in Q3 2025, an estimated $1.48K.
RhumbLine Advisers first reported a position in Concord Medical Services in Q2 2023 and held it in 9 quarters.
RhumbLine Advisers's Concord Medical Services position peaked at $18.9K in Q2 2024.
5 funds tracked by Wall St. Rank held Concord Medical Services as of Q3 2025.

Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.